104 results
Page 3 of 6
POSASR
7olvohwmc1 ivu12
28 Feb 22
Automatic shelf registration (post-effective amendment)
4:16pm
8-K
crp8eshy0
5 Jan 22
Sutro Biopharma Announces Interim Data from Dose-Expansion Cohort of STRO-002 Phase 1 Study for Patients with Advanced Ovarian Cancer
5:27pm
8-K
EX-99.1
3pm7icz tb443hk3ff5
5 Jan 22
Sutro Biopharma Announces Interim Data from Dose-Expansion Cohort of STRO-002 Phase 1 Study for Patients with Advanced Ovarian Cancer
5:27pm
8-K
EX-99.1
4iebdxiquf uh
10 Nov 21
Sutro Biopharma Reports Third Quarter 2021 Financial Results, Business Highlights, and Anticipated 2021 Milestones
7:03am
8-K
quls9ds1f5kgak
30 Sep 21
Other Events
7:00am
8-K
EX-99.1
xinfn
9 Aug 21
Business Highlights and Anticipated Second Half 2021 Milestones
7:01am
S-8
2v7wjxf ffk1rw6hi8v0
9 Aug 21
Registration of securities for employees
12:00am
8-K
EX-99.1
9miwmp
19 May 21
Regulation FD Disclosure
5:00pm
8-K
EX-99.1
xqawad 5uedp6
7 May 21
Business Highlights and 2021 Anticipated Milestones
7:00am
8-K
010m7du zel7bjk
15 Apr 21
Other Events
7:00am
S-3ASR
EX-1.2
b2l1wytrk00jd
2 Apr 21
Automatic shelf registration
4:59pm
S-3ASR
83hu09 wx
2 Apr 21
Automatic shelf registration
4:59pm
8-K
EX-99.1
sw2q39w ga
18 Mar 21
Sutro Biopharma Reports Full Year 2020 Financial Results
7:00am